Catheter Precision (FRA:4RM) EPS (Basic): €-11.75 (TTM As of Mar. 2026)


FRA:4RM Catheter Precision Inc FRA:4RM
23 GF Score
Price €100.89
GF Value €218.38
! 7 Warning Signs
View Full Analysis

What is Catheter Precision EPS (Basic)?

Catheter Precision FRA:4RM 23 EPS (Basic) is €-11.75 as of Mar. 2026. GuruFocus rates FRA:4RM with a GF Score™ of 23/100 and a GF Value™ of €218.38. The stock has 7 warning signs investors should review.

Catheter Precision's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €-1.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-11.75.

Catheter Precision's EPS (Diluted) for the three months ended in Mar. 2026 was €-1.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-11.75.

Catheter Precision's EPS without NRI for the three months ended in Mar. 2026 was €-1.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -4.69.

During the past 3 years, the average EPS without NRI Growth Rate was 89.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 86.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Catheter Precision's highest 3-Year average EPS without NRI Growth Rate was 89.40% per year. The lowest was -125.20% per year. And the median was 83.70% per year.

Catheter Precision  (FRA:4RM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Catheter Precision EPS (Basic) Related Terms

Catheter Precision EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Catheter Precision's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catheter Precision EPS (Basic) Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30,104.41 -4,659.77 -2,262.90 -121.20 -13.58

Catheter Precision Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.30 -6.26 -1.45 -2.84 -1.20
FRA:4RM
23GF Score
Catheter Precision Inc FRA:4RM
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Catheter Precision EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Catheter Precision's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-14.674-0)/1.081
=-13.57

Catheter Precision's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.454-0)/2.192
=-0.66

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-11.75 mean?
Catheter Precision (FRA:4RM) has a EPS (Basic) of €-11.75 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Catheter Precision and its competitors.
Is Catheter Precision's EPS (Basic) too high?
Catheter Precision's current EPS (Basic) is €-11.75. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's EPS (Basic) compare to ALURD and BJDX?
Catheter Precision's EPS (Basic) of €-11.75 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Catheter Precision and its competitors. Catheter Precision's current EPS (Basic) is €-11.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current EPS (Basic) of €-11.75. The stock's GF Value™ is €218.38, compared to a current price of €100.89 — trading 53.8% below its estimated fair value. The current EPS (Basic) is €-11.75. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current EPS (Basic) is €-11.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (FRA:4RM) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of €100.89 is trading 53.8% below its estimated GF Value™ of €218.38.

Key valuation signals for FRA:4RM:

  • EPS (Basic): €-11.75
  • GF Value™: €218.38 vs. price of €100.89 (53.8% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Other Exchanges VTAK:USA
Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for FRA:4RM

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€100.89
Price
€218.38
GF Value